Sort
53,477 grants matching “addiction”
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
$478,490Christine Elizabeth Sheffer · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Targeting AVIL, a novel oncogene in rhabdomyosarcoma
$478,467Hui Li · University Of Virginia · R01 · FY2024 · CA
Integrative Genetics and Genomics Core
$478,440Vivek Philip · Jackson Laboratory · P50 · FY2022 · DA
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain
$478,432Dong Wang · University Of Nebraska Medical Center · R01 · FY2023 · AR
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain
$478,432Dong Wang · University Of Nebraska Medical Center · R01 · FY2022 · AR
Informed Data-Driven Fusion of Behavior, Brain Function, and Genes
$478,392Vince D Calhoun · The Mind Research Network · R01 · FY2012 · EB
Shared Neural Circuitry in Comorbid Schizophrenia and Nicotine Addiction
$478,367L. Elliot Hong · University Of Maryland Baltimore · R01 · FY2014 · DA
Project 2 - Protein Ubiquitylation in Esophageal Cancer
$478,330J. Alan Diehl · Columbia University Health Sciences · P01 · FY2020 · CA
Targeting oncogenic dopamine receptor signaling in glioblastoma
$478,299Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
OpenBeds: Improving the Delivery of Care for Patients with Drug Addiction
$478,284Surendra Rawat · Openbeds, Inc. · R44 · FY2018 · DA
Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse
$478,257Stephen John Lewis · Case Western Reserve University · U01 · FY2021 · DA
Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse
$478,257Stephen John Lewis · Case Western Reserve University · U01 · FY2022 · DA
A Comparison of Buprenorphine Versus Morphine in the Treatment of the Neonatal Ab
$478,202Walter K. Kraft · Thomas Jefferson University · R01 · FY2016 · DA
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction
$478,187Subramaniam Ananthan · Southern Research Institute · R01 · FY2009 · DA
Training in Molecular Pharmacology of Abused Drugs
$478,149Paul E. M. Phillips · University Of Washington · T32 · FY2020 · DA
Multisite Controlled Trial of Cocaine Vaccine (1of 6) Lead Site/ Houston Treatmen
$478,141Thomas Richard Kosten · Baylor College Of Medicine · R01 · FY2008 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology
$478,136Debra A Kendall · University Of Connecticut Storrs · R01 · FY2019 · DA
Computer Assisted System for Patient Assessment/Referral
$478,091Deni Carise · Treatment Research Institute · R01 · FY2008 · AA
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
$477,994Brad Alan Grueter · Vanderbilt University Medical Center · R01 · FY2023 · DA
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
$477,967Brad Alan Grueter · Vanderbilt University Medical Center · R01 · FY2025 · DA
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
$477,967Brad Alan Grueter · Vanderbilt University Medical Center · R01 · FY2024 · DA
Neurochemical & Behavioral Correlates of ETOH Effects
$477,966Kimberly Nixon · University Of Texas At Austin · T32 · FY2025 · AA
Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer
$477,966Nupam P Mahajan · Washington University · R01 · FY2023 · CA
Intracranial Drug Self-administration
$477,861Satoshi Ikemoto · National Institute On Drug Abuse · ZIA · FY2013 · DA
Optogenetic investigations of motivational circuits in rats and mice
$477,861Satoshi Ikemoto · National Institute On Drug Abuse · ZIA · FY2013 · DA